Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,600 | 56,900 | 110,700 | 105,200 | 165,200 |
| Marketable Securities | 25,100 | 58,000 | 82,500 | 99,900 | 103,200 |
| Receivables | 119,100 | 101,600 | 102,200 | 109,800 | 101,700 |
| Inventories | 21,800 | 20,100 | 19,600 | 15,400 | 15,600 |
| TOTAL | $261,600 | $274,600 | $352,300 | $367,100 | $427,400 |
| Non-Current Assets | |||||
| PPE Net | 96,300 | 83,400 | 67,500 | 52,800 | 45,700 |
| Investments And Advances | 30,400 | 54,800 | 66,000 | 78,500 | 70,800 |
| Intangibles | 656,500 | 666,500 | 607,300 | 620,100 | 632,400 |
| Other Non-Current Assets | 124,500 | 119,400 | 118,900 | 91,700 | 79,100 |
| TOTAL | $907,700 | $924,100 | $859,700 | $843,100 | $828,000 |
| Total Assets | $1,169,300 | $1,198,700 | $1,212,000 | $1,210,200 | $1,255,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 36,500 | 28,800 | 29,600 | 21,700 | 27,100 |
| Accrued Expenses | 91,700 | 94,300 | 85,300 | 84,400 | 124,800 |
| TOTAL | $143,300 | $137,200 | $129,100 | $119,700 | $166,000 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 200 | 300 | 700 |
| Other Non-Current Liabilities | 186,700 | 175,700 | 155,800 | 119,800 | 109,400 |
| TOTAL | $190,800 | $175,700 | $166,300 | $143,100 | $139,300 |
| Total Liabilities | $334,100 | $312,900 | $295,400 | $262,800 | $305,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 81,555 | 81,224 | 81,034 | 80,635 | 80,343 |
| Common Shares | 800 | 800 | 800 | 800 | 800 |
| Retained earnings | -420,900 | -366,200 | -323,900 | -288,800 | -274,700 |
| Other shareholders' equity | -7,400 | -8,900 | -11,300 | -8,900 | -7,600 |
| TOTAL | $835,200 | $885,800 | $916,600 | $947,400 | $950,100 |
| Total Liabilities And Equity | $1,169,300 | $1,198,700 | $1,212,000 | $1,210,200 | $1,255,400 |